BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32819969)

  • 1. Hyperglycemia Enhances Cancer Immune Evasion by Inducing Alternative Macrophage Polarization through Increased O-GlcNAcylation.
    Rodrigues Mantuano N; Stanczak MA; Oliveira IA; Kirchhammer N; Filardy AA; Monaco G; Santos RC; Fonseca AC; Fontes M; Bastos CS; Dias WB; Zippelius A; Todeschini AR; Läubli H
    Cancer Immunol Res; 2020 Oct; 8(10):1262-1272. PubMed ID: 32819969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis.
    Rajamani U; Essop MF
    Am J Physiol Cell Physiol; 2010 Jul; 299(1):C139-47. PubMed ID: 20410435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of glycosylation in the polarization of tumor-associated macrophages.
    Mantuano NR; Oliveira-Nunes MC; Alisson-Silva F; Dias WB; Todeschini AR
    Pharmacol Res; 2019 Aug; 146():104285. PubMed ID: 31132403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.
    Vasconcelos-Dos-Santos A; de Queiroz RM; da Costa Rodrigues B; Todeschini AR; Dias WB
    J Bioenerg Biomembr; 2018 Jun; 50(3):175-187. PubMed ID: 29322286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.
    Hanover JA; Chen W; Bond MR
    J Bioenerg Biomembr; 2018 Jun; 50(3):155-173. PubMed ID: 29594839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hyperglycemia induces tau hyperphosphorylation by downregulating OGT-involved O-GlcNAcylation in vivo and in vitro.
    Huang R; Tian S; Zhang H; Zhu W; Wang S
    Brain Res Bull; 2020 Mar; 156():76-85. PubMed ID: 31931119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
    Phillips RM; Lam C; Wang H; Tran PT
    Adv Cancer Res; 2019; 142():23-62. PubMed ID: 30885363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
    Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
    J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights: A role for O-GlcNAcylation in diabetic complications.
    Peterson SB; Hart GW
    Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications.
    Qin CX; Sleaby R; Davidoff AJ; Bell JR; De Blasio MJ; Delbridge LM; Chatham JC; Ritchie RH
    Pharmacol Res; 2017 Feb; 116():45-56. PubMed ID: 27988387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperglycemia modulates M1/M2 macrophage polarization via reactive oxygen species overproduction in ligature-induced periodontitis.
    Zhang B; Yang Y; Yi J; Zhao Z; Ye R
    J Periodontal Res; 2021 Oct; 56(5):991-1005. PubMed ID: 34190354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
    Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
    Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of O-GlcNAc in chronic diseases of aging.
    Banerjee PS; Lagerlöf O; Hart GW
    Mol Aspects Med; 2016 Oct; 51():1-15. PubMed ID: 27259471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-GlcNAc elevation through activation of the hexosamine biosynthetic pathway enhances cancer cell chemoresistance.
    Liu Y; Cao Y; Pan X; Shi M; Wu Q; Huang T; Jiang H; Li W; Zhang J
    Cell Death Dis; 2018 May; 9(5):485. PubMed ID: 29706631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repetitive Intermittent Hyperglycemia Drives the M1 Polarization and Inflammatory Responses in THP-1 Macrophages Through the Mechanism Involving the TLR4-IRF5 Pathway.
    Al-Rashed F; Sindhu S; Arefanian H; Al Madhoun A; Kochumon S; Thomas R; Al-Kandari S; Alghaith A; Jacob T; Al-Mulla F; Ahmad R
    Cells; 2020 Aug; 9(8):. PubMed ID: 32806763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hexosamine Biosynthetic Pathway and Glycosylation Regulate Cell Migration in Melanoma Cells.
    de Queiroz RM; Oliveira IA; Piva B; Bouchuid Catão F; da Costa Rodrigues B; da Costa Pascoal A; Diaz BL; Todeschini AR; Caarls MB; Dias WB
    Front Oncol; 2019; 9():116. PubMed ID: 30891426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling.
    Ferrer CM; Sodi VL; Reginato MJ
    J Mol Biol; 2016 Aug; 428(16):3282-3294. PubMed ID: 27343361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.
    Efimova EV; Appelbe OK; Ricco N; Lee SS; Liu Y; Wolfgeher DJ; Collins TN; Flor AC; Ramamurthy A; Warrington S; Bindokas VP; Kron SJ
    Mol Cancer Res; 2019 Jun; 17(6):1338-1350. PubMed ID: 30885991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.